Dr. Oleksandra Lupak
Claim this profileRalph H Johnson VA Medical Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
24 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
MET positive
EGFR positive
2Lung Cancer
Stage IV
EGFR positive
ALK positive
Affiliated Hospitals
Clinical Trials Oleksandra Lupak is currently running
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting2 awards Phase 332 criteria
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting1 award Phase 2 & 320 criteria
More about Oleksandra Lupak
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Oleksandra Lupak has experience with
- Lenalidomide
- Nivolumab
- Oxaliplatin
- Daratumumab/rHuPH20
- Screening Platform
- Dexamethasone
Breakdown of trials Oleksandra Lupak has run
Non-Small Cell Lung Cancer
Lung Cancer
Rectal Cancer
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Oleksandra Lupak specialize in?
Oleksandra Lupak focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are MET positive.
Is Oleksandra Lupak currently recruiting for clinical trials?
Yes, Oleksandra Lupak is currently recruiting for 6 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Oleksandra Lupak has studied deeply?
Yes, Oleksandra Lupak has studied treatments such as Lenalidomide, Nivolumab, Oxaliplatin.
What is the best way to schedule an appointment with Oleksandra Lupak?
Apply for one of the trials that Oleksandra Lupak is conducting.
What is the office address of Oleksandra Lupak?
The office of Oleksandra Lupak is located at: Ralph H Johnson VA Medical Center, Charleston, South Carolina 29401 United States. This is the address for their practice at the Ralph H Johnson VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.